The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review

Introduction: Few studies have described their experience using esmolol, an ultra-short acting β-adrenergic antagonist, in the emergency department (ED) as a feasible adjuvant therapy for the treatment of refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital...

Full description

Bibliographic Details
Main Authors: Dennis Miraglia, Lourdes A. Miguel, Wilfredo Alonso
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2020-03-01
Series:Archives of Academic Emergency Medicine
Subjects:
Online Access:https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/553

Similar Items